Abbott (ABT)
100.26
+0.59 (0.59%)
Upcoming Events
Latest Headlines
Abbott Labs (ABT) Reiterated at Buy by Benchmark After Q2 Model Updates
July 20, 2026 7:26 AM - StreetInsider
Abbott Labs (ABT) PT Raised to $117 at Bernstein SocGen Group
July 17, 2026 8:48 AM - StreetInsider
Abbott Labs (ABT) Reiterated at Buy by Benchmark After Q2 Revenue Beat
July 17, 2026 7:36 AM - StreetInsider
Abbott Labs (ABT) PT Raised to $120 at JPMorgan
July 17, 2026 7:24 AM - StreetInsider
Abbott Labs (ABT) PT Raised to $118 at Piper Sandler
July 17, 2026 6:46 AM - StreetInsider
Abbott Labs (ABT) PT Raised to $112 at Wells Fargo
July 17, 2026 6:42 AM - StreetInsider
Abbott Labs (ABT) PT Raised to $134 at BTIG
July 16, 2026 4:00 PM - StreetInsider
Abbott beats second-quarter estimates, raises 2026 guidance
July 16, 2026 7:43 AM - StreetInsider
Form 8-K ABBOTT LABORATORIES For: Jul 16
July 16, 2026 7:36 AM - SEC Filing
Abbott (ABT) Tops Q2 EPS by 3c; offers guidance
July 16, 2026 7:32 AM - StreetInsider
Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance
July 16, 2026 7:30 AM - PR NewsWire
Abbott (ABT) call put ratio 1 call to 1.3 puts into quarter results
July 15, 2026 11:32 AM - StreetInsider
Benchmark Reiterates Buy Rating on Abbott Labs (ABT) Ahead of Q2 Results
July 15, 2026 9:24 AM - StreetInsider
U.S. MedTech stocks: Q2 earnings preview
July 12, 2026 10:00 AM - StreetInsider
Reckitt Unit Cleared By Jury In Premature-infant Formula Case - Bloomberg
July 2, 2026 12:03 PM - StreetInsider
Form 4 ABBOTT LABORATORIES For: Jun 30 Filed by: Stratton John G
July 1, 2026 6:00 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Jun 30 Filed by: Roman Michael F
July 1, 2026 5:54 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Jun 30 Filed by: Gonzalez Patricia Paola
July 1, 2026 5:41 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Jun 30 Filed by: Conroy Kevin T
July 1, 2026 5:28 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Jun 30 Filed by: Ahuja Nita
July 1, 2026 5:16 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Jun 30 Filed by: Morrone Louis H.
July 1, 2026 5:04 PM - SEC Filing
Baird starts Abbott at Outperform, sees product pipeline driving growth
July 1, 2026 2:39 PM - StreetInsider
Baird Starts Abbott Labs (ABT) at Outperform, 'Set to Improve with Catalysts Ahead'
June 30, 2026 4:22 PM - StreetInsider
Form 4 ABBOTT LABORATORIES For: Jun 27 Filed by: Cushman Elizabeth C.
June 29, 2026 5:34 PM - SEC Filing
Abbott hosts conference call for second-quarter earnings
June 25, 2026 9:01 AM - PR NewsWire
ALZpath licenses pTau217 antibody to Abbott for Alzheimer's blood test
June 24, 2026 8:30 AM - StreetInsider
ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease Testing
June 24, 2026 8:30 AM - PR NewsWire
New Similac® survey finds social media pressure to be "perfect" is fueling a shift toward authenticity for the next generation of parents
June 22, 2026 12:00 PM - PR NewsWire
Piper Sandler on Abbott Labs (ABT): 'A Name Worth Revisiting'
June 22, 2026 9:45 AM - StreetInsider
Form 4 ABBOTT LABORATORIES For: May 07 Filed by: Stratton John G
June 18, 2026 5:08 PM - SEC Filing
Form 11-K ABBOTT LABORATORIES For: Dec 31
June 18, 2026 4:09 PM - SEC Filing
Abbott (ABT) Declares $0.63 Quarterly Dividend; 2.9% Yield
June 12, 2026 2:38 PM - StreetInsider
Abbott declares 410th consecutive quarterly dividend
June 12, 2026 2:29 PM - PR NewsWire
New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired with support from community health workers
June 8, 2026 9:00 AM - PR NewsWire
Abbott study finds diabetic ketoacidosis often goes unrecognized
June 6, 2026 9:03 AM - StreetInsider
New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis
June 6, 2026 9:00 AM - PR NewsWire
Form SD ABBOTT LABORATORIES
May 27, 2026 4:48 PM - SEC Filing
Abbott receives CE Mark for dual glucose-ketone diabetes sensor
May 27, 2026 9:01 AM - StreetInsider
Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes
May 27, 2026 9:01 AM - PR NewsWire
American Cancer Society reaffirms Abbott colorectal screening tests
May 27, 2026 7:02 AM - StreetInsider
ACS guideline reaffirms Abbott leadership in noninvasive colorectal cancer screening
May 27, 2026 7:01 AM - PR NewsWire
Abbott showcases expanding evidence across its cancer diagnostics portfolio at ASCO 2026
May 26, 2026 9:00 AM - PR NewsWire
Form 144 ABBOTT LABORATORIES Filed by: Alpern Robert J
May 15, 2026 4:22 PM - SEC Filing
Abbott’s dividend yield near decade peak, signaling rare buying opportunity
May 12, 2026 1:07 PM - StreetInsider
Goldman Makes Monthly Adjustment to Regional Directors' Cut List in US
May 1, 2026 5:14 AM - StreetInsider
Form 4 ABBOTT LABORATORIES For: Apr 28 Filed by: Moreland Mary K
April 29, 2026 5:09 PM - SEC Filing
Form SCHEDULE 13G ABBOTT LABORATORIES Filed by: VANGUARD CAPITAL MANAGEMENT LLC
April 29, 2026 4:44 PM - SEC Filing
Form 10-Q ABBOTT LABORATORIES For: Mar 31
April 29, 2026 4:06 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Apr 24 Filed by: Conroy Kevin T
April 28, 2026 8:08 PM - SEC Filing
Form 3 ABBOTT LABORATORIES For: Apr 24 Filed by: Conroy Kevin T
April 28, 2026 7:59 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Apr 24 Filed by: Stratton John G
April 28, 2026 7:45 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Apr 24 Filed by: STARKS DANIEL J
April 28, 2026 7:38 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Apr 24 Filed by: Roman Michael F
April 28, 2026 7:21 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Apr 24 Filed by: O'Grady Michael
April 28, 2026 7:14 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Apr 24 Filed by: McKinstry Nancy
April 28, 2026 7:03 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Apr 24 Filed by: McDew Darren W
April 28, 2026 6:55 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Apr 24 Filed by: Kumbier Michelle
April 28, 2026 6:46 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Apr 24 Filed by: Gonzalez Patricia Paola
April 28, 2026 6:27 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Apr 24 Filed by: Blount Sally E.
April 28, 2026 6:17 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Apr 24 Filed by: Babineaux-Fontenot Claire
April 28, 2026 6:09 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Apr 24 Filed by: Ahuja Nita
April 28, 2026 6:02 PM - SEC Filing
Abbott receives FDA clearance for AI-powered coronary imaging platform
April 28, 2026 9:02 AM - StreetInsider
Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform
April 28, 2026 9:02 AM - PR NewsWire
Form 144 ABBOTT LABORATORIES Filed by: Alpern Robert J
April 27, 2026 6:34 PM - SEC Filing
Form 4 ABBOTT LABORATORIES For: Apr 23 Filed by: Boudreau Philip P
April 27, 2026 5:35 PM - SEC Filing
Form 8-K ABBOTT LABORATORIES For: Apr 24
April 27, 2026 4:08 PM - SEC Filing
Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026
April 25, 2026 12:30 PM - PR NewsWire
Form S-8 ABBOTT LABORATORIES
April 24, 2026 4:08 PM - SEC Filing
Full Article List
